C3.ai (AI), a prominent player in enterprise artificial intelligence, recently sent a ripple through Wall Street with its preliminary July quarter results. The company’s own description of these outcomes as “completely unacceptable” set the tone for the turmoil that followed. 

On Aug. 11, shares of AI stock tumbled nearly 26%, a clear signal that investors were not buying into the explanations provided. CEO Tom Siebel candidly attributed the shortfall to personal health challenges that distracted him from fully steering the business, alongside a disruptive internal reorganization that unsettled operations. 

Despite the setback, Siebel remains steadfast, highlighting strong products, an expansive market opportunity, and high customer satisfaction as pillars for a potential comeback. Yet, the mood on Wall Street is far from optimistic. Analysts have not minced words, with some labeling the quarter as “brutal” and even “catastrophic.”

The road ahead appears steep, as the full first-quarter fiscal 2026 results, due Sept. 3, will be scrutinized for signs of a genuine turnaround.

About C3.ai Stock

Headquartered in Redwood City, California, C3.ai specializes in enterprise artificial intelligence software applications. The company delivers solutions that enable businesses to swiftly develop, deploy, and manage AI-driven applications across diverse sectors. With a market capitalization hovering around $2.5 billion currently, the firm offers an integrated suite encompassing the C3 AI Platform, C3 AI Applications, and the newer C3 Generative AI.

Over the past 52 weeks, AI stock has taken a significant hit, declining by 28%. More recently, in the last month alone, shares have plunged 32%, indicating the intensity of concern following the preliminary results. 

Valued at approximately 5.8 times sales, AI stock trades at a premium compared to its industry peers. The premium may expose the stock to greater volatility, especially as operational challenges emerge. 

C3.ai Surpasses Q4 Earnings

On May 28, C3.ai unveiled its Q4 fiscal 2025 results, beating Wall Street's estimates. Revenue rose 26% year-over-year (YOY) to $108.7 million, narrowly surpassing the consensus figure of $108.53 million. The company reported a GAAP gross profit of $67.5 million, translating to a healthy 62% gross margin.

Adjusted non-GAAP net loss per share came in at $0.16, outperforming analyst projections of a $0.20 per-share loss. The balance sheet showed strength, with cash and equivalents totaling $742.7 million. 

However, the optimism was short-lived. The recently announced preliminary Q1 fiscal 2026 results sharply deviated from expectations, sparking upheaval in AI stock. The company responded by announcing a sales force overhaul, bringing in a new chief commercial officer and other senior executives to address critical weaknesses. 

The updated guidance for Q1 2026 forecast revenue between $70.2 million and $70.4 million, far below prior expectations of $100 million to $109 million. Meanwhile, adjusted operating loss widened dramatically to a range of $57.7 million to $59.9 million, compared to earlier forecasts of $23.5 million to $33.5 million. 

Meanwhile, analysts expect Q1 2026 loss per share to widen 26% YOY to $0.63. For fiscal 2026, loss per share is estimated to widen 7% to $2.35, then narrow 12% to $2.06 in fiscal 2027.

What Do Analysts Expect for C3.ai Stock?

The analyst community has responded decisively to the recent developments at C3.ai. Wedbush analyst Daniel Ives reduced the price target from $35 to $23 while maintaining an Outperform rating, underscoring the severity of what he termed “a brutal quarter.” 

DA Davidson went further, cutting its rating to “Underperform” from “Neutral” and slashing the price target from $25 to $13, describing the results as “catastrophic.”

Analysts currently assign AI stock with an overall “Hold” rating. Across the 14 analysts covering the stock, three recommend a “Strong Buy,” five suggest “Hold,” two rate it as a “Moderate Sell,” and four analysts advise a “Strong Sell" rating.

C3.ai stock’s average price target of $27.46 represents potential upside of 52% from here. Meanwhile, the Street-high target of $50 suggests a potential climb of 177% from current levels — if the company can successfully execute its turnaround plan.